Enanta Pharmaceuticals, Inc.
Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

Last updated:

Abstract:

The present invention provides compounds of Formula I, ##STR00001## Pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.

Status:
Grant
Type:

Utility

Filling date:

25 Oct 2017

Issue date:

24 Mar 2020